Allon Therapeutics, Inc. operates as a clinical-stage biotechnology company, which engages in the development of drugs to treat neurodegenerative diseases and disorders. It focuses and provides central nervous system therapies. The company was founded by Illana Gozes and Richard P. Burgoon on March 24, 1994 and is headquartered in Vancouver, Canada.